Digital twins for clinical trials: early days, rapid momentum
In recent years, automation and artificial intelligence (AI) have been huge trends within the clinical trials landscape, as companies look …
In recent years, automation and artificial intelligence (AI) have been huge trends within the clinical trials landscape, as companies look …
is is the fourth episode in our Insights Uncovered: A Real-World Data Podcast Series, exploring the evolving landscape of real-world …
Gilead Sciences is preparing to file for approval of its single-tablet anti-retroviral therapy (ART) combination in human immunodeficiency virus (HIV) …
Matisse Pharmaceuticals has reported encouraging top line results from a Phase I trial of a 120-hour continuous intravenous (IV) infusion …
Opus Genetics has dosed the first subject in its Phase I/II clinical trial of OPGx-Best1 gene therapy for the treatment …
The 2020s thus far have been fraught with unforeseen circumstances with pharmaceutical companies working through everything from a global pandemic …
Obstructive sleep apnea (OSA) is a condition in which airflow is blocked during sleep for longer than 10 seconds at …
The US Food and Drug Administration (FDA) has created a new pathway to bring personalised therapies to market that can …
WCG, a tech-enabled partner with over 55 years’ experience accelerating clinical research while safeguarding participant safety, won the Innovation Award …
Novartis’ anti-malaria drug could mark the first major advancement in more than 25 years after it showed non-inferiority in a …
Advarra and IgniteData have formed a partnership to facilitate secure transfer of clinical trial data between research sites’ Advarra’s eSource …
Amid the European Commission’s (EC’s) public consultation on the EU Biotech Act, EuropaBio has called for the EU to adopt …
WCG has introduced Data & Insights Solutions for optimising and expediting clinical study outcomes. The company aims to transform the trial …
White space refers to unproductive gaps in drug development, when progress stalls due to scientific barriers or because of process, …
Neurogene has announced encouraging interim clinical data in the paediatric cohort from its ongoing Phase I/II trial of NGN-401 gene …